Axon Therapies
PrivateLast Round
Series A
Sep 25, 2025
Total Funding Raised
$32M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Axon Therapies is a medical technology company that develops minimally invasive, implant-free therapies to address the root causes of heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axon Therapies Comparables
Compare Axon Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alleviant Medical | 83% | |
| Ancora Heart | 81% | |
| Berlin Heals Holding AG | 80% |
Axon Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 25, 2025 | ||||
| VC Round | Jan 1, 2019 |
Key People
Founding team and executive leadership
Axon Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | VC Round, Series A |
| KOFA Healthcare | Series A |
| Action Potential Venture Capital | VC Round |
| Santé Ventures | Series A |
| Earlybird Venture Capital | Series A |
| Santé Ventures | Series A |
| CD Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2025
$32M round completed.
- Sep 25, 2025
Zoar Engelman appointed CEO to lead clinical development.
Axon Therapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Axon Therapies's valuation, stock price, and market status.
Is Axon Therapies a public or private company?
Axon Therapies is a private company.
What is the current stock price of Axon Therapies?
Axon Therapies is a private company with no public stock price. No recent secondary market data is available.
How much is Axon Therapies worth (valuation)?
Valuation information for Axon Therapies is not publicly available.
Can I buy Axon Therapies stock?
Axon Therapies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Axon Therapies's last funding round?
Axon Therapies's most recent funding round was Series A on September 25, 2025.
Who are the main investors in Axon Therapies?
Key investors in Axon Therapies include Santé Ventures, Earlybird Venture Capital, Santé Ventures.
Will Axon Therapies IPO soon?
No public IPO plans have been announced for Axon Therapies.
How can I track Axon Therapies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axon Therapies's secondary market activity and sign up for updates.